ShockWave Medical is a medical device company. Co. is provides a way of care for medical device treatment of atherosclerotic cardiovascular disease through its sonic pressure waves for the treatment of calcified plaque, which it refers to as intravascular lithotripsy (IVL). Co.'s products for treatment of peripheral artery disease (PAD) includes its Shockwave M5 IVL catheter used for the treatment of above-the-knee PAD and its Shockwave S4 IVL catheter used for the treatment of below-the-knee PAD. Co.'s product for the treatment of coronary artery disease (CAD) includes its Shockwave C2 IVL catheter. The SWAV stock yearly return is shown above.
The yearly return on the SWAV stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the SWAV annual return calculation with any dividends reinvested as applicable (on ex-dates).
|